What does Vesale Pharmaceutica do?
VESALE PHARMACEUTICA specializes in the development and manufacturing of high-quality pharmaceuticals. The company focuses on innovative solutions to meet the needs of healthcare professionals and patients. With a commitment to excellence, VESALE PHARMACEUTICA aims to enhance the effectiveness of treatments in various medical fields.
- Sectors
- Wholesalers
- Signals
-
Reporting lossesReporting losses € -363K
The company reported a loss in the latest financial year.
Strong equityStrong equity € 3.10MStrong equity provides a buffer against setbacks.
Low riskLow risk 77.1%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 3.52A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 827KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 1.42MPositive EBITDA: operating activities are profitable.
Healthy social debtHealthy social debt 11.6%Social debts stay manageable relative to personnel costs.
- Directors
- Md Consult Sa, Aquitania Sa, Vesale Pharma International Sa, +3 more
- Shareholders
- Ceres Pharma 100%
Financial ratios
|
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
€
2.20M
|
€
1.05M
|
€
949K
|
€
1.07M
|
|
|
€
1.42M
|
€
521K
|
€
364K
|
€
517K
|
|
|
€
-363K
|
€
243K
|
€
87K
|
€
340K
|
|
|
€
3.10M
|
€
3.47M
|
€
3.11M
|
€
3.02M
|
|
|
77.12%
|
76.64%
|
64.34%
|
55.25%
|
|
|
€
921K
|
€
1.06M
|
€
1.72M
|
€
2.44M
|
|
|
€
1.51M
|
€
121K
|
€
98K
|
€
109K
|
|
|
2.50
|
2.50
|
5.00
|
5.80
|
Publications 37
All publications- Demissions, Nominations 06/07/2020
- Capital, Actions - Demissions, Nominations 10/06/2020
- Demissions, Nominations 19/07/2019
- Capital, Actions 24/04/2019
- Me. - Comptes Annuels 31.12.2015, App 30.06.2016, Dpt 24.08.2016 16466-0018-017 31/08/2016
Frequently asked questions
Answers to the most common questions about Vesale Pharmaceutica, based on official government data and the filed annual accounts.
What is the VAT number of Vesale Pharmaceutica?
The VAT number of Vesale Pharmaceutica is BE0452.282.591.
How many employees work at Vesale Pharmaceutica?
In 2025, Vesale Pharmaceutica employed 2.50 full-time equivalents (FTE).
When was Vesale Pharmaceutica established?
Vesale Pharmaceutica was founded in 16-03-1994.
What is the official address of Vesale Pharmaceutica?
The official address of Vesale Pharmaceutica is Rue Jean Sonet,Isnes 29 Gembloux 5032.
What is the legal form of Vesale Pharmaceutica?
The juridical form of Vesale Pharmaceutica is Public limited company (NV/SA).
What is the annual revenue of Vesale Pharmaceutica?
The 2025 accounts of Vesale Pharmaceutica do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Vesale Pharmaceutica do?
VESALE PHARMACEUTICA specializes in the development and manufacturing of high-quality pharmaceuticals. The company focuses on innovative solutions to meet the needs of healthcare professionals and patients. With a commitment to excellence, VESALE PHARMACEUTICA aims to enhance the effectiveness of treatments in various medical fields.
Is Vesale Pharmaceutica a reliable company?
Vesale Pharmaceutica is a registered Rechtspersoon with company number 0452.282.591 and can be verified through the official CBE database.
What is the credit limit of Vesale Pharmaceutica?
The estimated credit limit of Vesale Pharmaceutica is €1,531,397.
Is Vesale Pharmaceutica still active?
Vesale Pharmaceutica currently has the status "Normal situation" and is active.